These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15632187)

  • 1. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor.
    Archer-Lahlou E; Escrieut C; Clerc P; Martinez J; Moroder L; Logsdon C; Kopin A; Seva C; Dufresne M; Pradayrol L; Maigret B; Fourmy D
    J Biol Chem; 2005 Mar; 280(11):10664-74. PubMed ID: 15632187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the GRK2 binding site of Galphaq.
    Day PW; Tesmer JJ; Sterne-Marr R; Freeman LC; Benovic JL; Wedegaertner PB
    J Biol Chem; 2004 Dec; 279(51):53643-52. PubMed ID: 15471870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
    J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
    Sarri E; Ramos B; Salido GM; Claro E
    Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.
    Archer-Lahlou E; Tikhonova I; Escrieut C; Dufresne M; Seva C; Pradayrol L; Moroder L; Maigret B; Fourmy D
    J Med Chem; 2005 Jan; 48(1):180-91. PubMed ID: 15634012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K; Gigoux V; Escrieut C; Maigret B; Martinez J; Moroder L; Fréhel D; Gully D; Vaysse N; Fourmy D
    J Biol Chem; 1997 Jan; 272(5):2920-6. PubMed ID: 9006937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor.
    Galés C; Kowalski-Chauvel A; Dufour MN; Seva C; Moroder L; Pradayrol L; Vaysse N; Fourmy D; Silvente-Poirot S
    J Biol Chem; 2000 Jun; 275(23):17321-7. PubMed ID: 10748160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of phospholipase C by cholecystokinin receptor subtypes with different G-protein-coupling specificities in hormone-secreting pancreatic cell lines.
    Paulssen RH; Fraeyman N; Florholmen J
    Biochem Pharmacol; 2000 Sep; 60(6):865-75. PubMed ID: 10930542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.
    Gigoux V; Escrieut C; Fehrentz JA; Poirot S; Maigret B; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy D
    J Biol Chem; 1999 Jul; 274(29):20457-64. PubMed ID: 10400673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
    Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
    Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
    Tsunoda Y; Owyang C
    Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin.
    Langer I; Tikhonova IG; Travers MA; Archer-Lahlou E; Escrieut C; Maigret B; Fourmy D
    J Biol Chem; 2005 Jun; 280(23):22198-204. PubMed ID: 15817487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
    Nozu F; Tsunoda Y; Ibitayo AI; Bitar KN; Owyang C
    Am J Physiol; 1999 Apr; 276(4):G915-23. PubMed ID: 10198335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.
    Marchal-Victorion S; Vionnet N; Escrieut C; Dematos F; Dina C; Dufresne M; Vaysse N; Pradayrol L; Froguel P; Fourmy D
    Pharmacogenetics; 2002 Jan; 12(1):23-30. PubMed ID: 11773861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein subunits and the stimulation of phospholipase C by Gs-and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein.
    Zhu X; Birnbaumer L
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2827-31. PubMed ID: 8610126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.
    Desai AJ; Harikumar KG; Miller LJ
    J Biol Chem; 2014 Jun; 289(26):18314-26. PubMed ID: 24825903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements of CCK analogues to differentiate second messengers and pancreatic secretion.
    Tsunoda Y; Yoshida H; Owyang C
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G8-19. PubMed ID: 8760101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Ser153 in ICL2 of the gonadotropin-releasing hormone (GnRH) receptor as a phosphorylation-independent site for inhibition of Gq coupling.
    Shacham S; Cheifetz MN; Fridkin M; Pawson AJ; Millar RP; Naor Z
    J Biol Chem; 2005 Aug; 280(32):28981-8. PubMed ID: 15964850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.